TNFSF14 and plasma cell myeloma: Addition of three specific biomarkers (MDEs), i.e., 1) clonal bone marrow plasma cell percentage ≥60%; 2) involved:uninvolved serum-free light chain ratio ≥100; 3) >1 focal lesion on MRI studies (>5 mm)Presence of even one of these MDEs in the absence of CRAB is sufficient for myeloma diagnosisSingle 5-mm or larger osteolytic lesion seen at PET/CT, WBLD CT, or skeletal survey: CRAB